Advisor Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$51K Sell
850
-421
-33% -$18.9K ﹤0.01% 3400
2019
Q3
$47K Hold
1,271
﹤0.01% 3441
2019
Q2
$59K Buy
1,271
+112
+10% +$5.26K ﹤0.01% 3239
2019
Q1
$47K Buy
1,159
+212
+22% +$9.51K ﹤0.01% 3432
2018
Q4
$44K Buy
947
+291
+44% +$14K ﹤0.01% 3263
2018
Q3
$29K Buy
656
+593
+941% +$27.2K ﹤0.01% 3649
2018
Q2
$2K Sell
63
-912
-94% -$46.1K ﹤0.01% 4665
2018
Q1
$70K Buy
975
+654
+204% +$48K ﹤0.01% 2823
2017
Q4
$21K Hold
321
﹤0.01% 3690
2017
Q3
$17K Buy
321
+286
+817% +$13.8K ﹤0.01% 3643
2017
Q2
$2K Buy
+35
New +$1.29K ﹤0.01% 4504
2017
Q1
Sell
-200
Closed -$3K 4713
2016
Q4
$3K Sell
200
-14,237
-99% -$170K ﹤0.01% 4102
2016
Q3
$200K Buy
14,437
+85
+0.6% +$963 ﹤0.01% 1522
2016
Q2
$140K Buy
+14,352
New +$238K ﹤0.01% 1698

Other funds holding ESPR